Merck Total Assets from 2010 to 2026

MRK Stock   27.83  0.87  3.23%   
Merck CDR Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to drop to about 122.1 B. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2010-12-31
Previous Quarter
134.7 B
Current Value
122.1 B
Quarterly Volatility
B
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Merck CDR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck CDR's main balance sheet or income statement drivers, such as Tax Provision of 2.5 B, Interest Income of 1 B or Selling General Administrative of 11.5 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck CDR Valuation or Volatility modules.
  
This module can also supplement various Merck CDR Technical models . Check out the analysis of Merck CDR Correlation against competitors.
Evaluating Merck CDR's Total Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Merck CDR's fundamental strength.

Latest Merck CDR's Total Assets Growth Pattern

Below is the plot of the Total Assets of Merck CDR over the last few years. Total assets refers to the total amount of Merck CDR assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Merck CDR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Merck CDR's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merck CDR's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 117.11 B10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Merck Total Assets Regression Statistics

Arithmetic Mean111,741,839,216
Geometric Mean111,556,052,511
Coefficient Of Variation6.22
Mean Deviation4,544,794,002
Median109,160,000,000
Standard Deviation6,954,023,954
Sample Variance48358449.2T
Range28B
R-Value0.56
Mean Square Error35143794.3T
R-Squared0.32
Significance0.02
Slope777,404,984
Total Sum of Squares773735186.4T

Merck Total Assets History

2026122.1 B
2025134.7 B
2024117.1 B
2023106.7 B

About Merck CDR Financial Statements

Merck CDR investors utilize fundamental indicators, such as Total Assets, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Assets134.7 B122.1 B

Pair Trading with Merck CDR

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Merck CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck CDR will appreciate offsetting losses from the drop in the long position's value.

Moving together with Merck Stock

  0.88JNJ Johnson Johnson CDRPairCorr
  1.0MRK MerckPairCorr
  0.84AMGN Amgen CDRPairCorr

Moving against Merck Stock

  0.53VRY Petro Victory EnergyPairCorr
  0.37HWO High Arctic EnergyPairCorr
The ability to find closely correlated positions to Merck CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Merck CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Merck CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Merck CDR to buy it.
The correlation of Merck CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Merck CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Merck CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Merck CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Merck Stock

Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.